FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897078483> ?p ?o ?g. }

• W2897078483 abstract "HomeStrokeVol. 49, No. 11Response by Mazya et al to Letter Regarding Article, “Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR” Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBResponse by Mazya et al to Letter Regarding Article, “Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR” Michael V. Mazya, MD, PhD, Niaz Ahmed, MD, PhD and Tiago P. Moreira, MD, PhD Michael V. MazyaMichael V. Mazya Correspondence to Michael Mazya, SITS International Coordination Office, Department of Neurology, Karolinska University Hospital–Solna, 17176 Stockholm. Email E-mail Address: [email protected] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Search for more papers by this author , Niaz AhmedNiaz Ahmed Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Search for more papers by this author and Tiago P. MoreiraTiago P. Moreira Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Search for more papers by this author Originally published27 Sep 2018https://doi.org/10.1161/STROKEAHA.118.022660Stroke. 2018;49:e319Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: September 27, 2018: Ahead of Print In Response:We thank Drs Li and Zheng for showing interest in our article.1 Our main findings were that pre-intravenous thrombolysis (IVT) transcranial doppler (TCD) delayed IVT infusion by a median of 14 minutes. The first of our secondary analyses compared outcomes in patients who had received pre-IVT TCD and those who had not. This stemmed from a hypothesis that an increase in door-to-needle time caused by TCD might lead to worse outcomes. In unadjusted analysis, there were no significant differences between the groups on any outcomes, including SICH, as well as modified Rankin Scale (mRS) score 0 to 1, mRS 0 to 2, and death. Adjustment for baseline differences showed no signal of worse outcomes associated with TCD—on the contrary, there was a borderline significant association with modestly better odds for mRS 0 to 1 and mRS 0 to 2 at 3 months. Furthermore, we saw similar findings on patients who had undergone TCD during IVT infusion, avoiding the preinfusion delay.We had robust findings on the safety of TCD performed in both settings. At the same time, we emphasized the need for caution in interpreting signals of potential benefit. Part of this caution was elaborated as possible impact of beneficial local practice traditions associated with the use of TCD in selected cases. Such center effects and potential country effects can be handled using multilevel modeling, as Drs Li and Zheng correctly point out. We initially deemed this as sufficiently accounted for by the fact that all patient groups, including control groups unexamined with TCD, had been treated at TCD-performing centers, likely under similar diagnostic and treatment traditions associated with TCD use. We have reanalyzed our data in keeping with Drs Li and Zheng’s recommendation.For each outcome, we estimated a 3-level mixed-effect logistic regression model. The nested levels were country, center, and individual. The models included a normal random intercept for country and 1 for center. The set of independent variables used in each model are described in the article. We calculated intraclass correlations for within-center and with-country correlation. The intraclass correlations were slight, values ranging from 0,00 to 0,06 for all outcomes in all analyses. This implies that the logistic regression in the article, which assumed independence from center and country effect, was not far off. Still, in the multilevel models, the point estimates, although similar, were slightly lower for mRS 0 to 2 and mRS 0 to 1, with larger P values. The adjusted odds ratio for mRS 0–2 in Table 2 became 1.09; P=0.30 (from originally 1.15; P=0.043), and the adjusted odds ratio for mRS 0 to 1 in Table III in the online-only Data Supplement became 1.17; P=0.16 (from originally, 1.27; P=0.012). This can partly be accounted for by loss of power because of greater number of parameters in the multilevel models. However, association of during-IVT TCD with decreased mortality by 3 months remained significant after multilevel modeling, adjusted odds ratio, 0.71; P=0.025 (from originally, 0.73; P=0.022).Issues of multicollinearity had already been accounted for in our analyses in the article. Collinearity was seen between onset-to-treatment time and door-to-needle time (Table 2 in the article), which have a perfect correlation. They were not entered into the multivariate model together, but only one at a time, with no changes to the results. This was also seen in systolic and diastolic blood pressure, (Pearson coefficient, 0.5), where the same approach was taken in multivariate modeling. Prior hypertension was only weakly correlated with baseline systolic and diastolic blood pressure (Pearson coefficient, −0.2 and −0.1, respectively). In analyses pertaining to Table III in the online-only Data Supplement, prior hypertension was included in both models interchangeably, including baseline systolic blood pressure and diastolic blood pressure.We conclude that although center and country variance was low, the results following inclusion of center and country effect in the multivariate model confirmed the need to cautiously interpret associations of TCD use with improved outcomes. Our main conclusion, however, still holds that TCD examination, if performed, should be done during IVT infusion to avoid treatment delay.Michael V. Mazya, MD, PhDNiaz Ahmed, MD, PhDTiago P. Moreira, MD, PhDDepartment of Clinical NeuroscienceKarolinska InstitutetStockholm, SwedenAcknowledgmentsWe gratefully acknowledge the statistical assistance of Prof. Matteo Bottai, Biostatistics Core Facility, Karolinska Institutet, Stockholm, Sweden.DisclosuresThe authors hold positions within SITS International (Safe Implementation of Treatments in Stroke International). SITS receives an unrestricted grant from Boehringer Ingelheim. T. Moreira has received compensation from Cerevast Inc, lecture and travel grants from Philips and Boehringer Ingelheim.FootnotesStroke welcomes Letters to the Editor and will publish them, if suitable, as space permits. Letters must reference a Stroke published-ahead-of-print article or an article printed within the past 4 weeks. The maximum length is 750 words including no more than 5 references and 3 authors. Please submit letters typed double-spaced. Letters may be shortened or edited.Correspondence to Michael Mazya, SITS International Coordination Office, Department of Neurology, Karolinska University Hospital–Solna, 17176 Stockholm. Email michael.[email protected]seReference1. Mazya MV, Ahmed N, Azevedo E, Davalos A, Dorado L, Karlinski M, et al; SITS Investigators. Impact of transcranial Doppler ultrasound on logistics and outcomes in stroke thrombolysis: results from the SITS-ISTR.Stroke. 2018; 49:1695–1700. doi: 10.1161/STROKEAHA.118.021485LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails November 2018Vol 49, Issue 11 Advertisement Article InformationMetrics © 2018 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.118.022660PMID: 30355223 Originally publishedSeptember 27, 2018 PDF download Advertisement SubjectsIschemic StrokeTreatmentUltrasound" @default.
• W2897078483 created "2018-10-26" @default.
• W2897078483 creator A5002192023 @default.
• W2897078483 creator A5015220387 @default.
• W2897078483 creator A5024953656 @default.
• W2897078483 date "2018-11-01" @default.
• W2897078483 modified "2023-10-01" @default.
• W2897078483 title "Response by Mazya et al to Letter Regarding Article, “Impact of Transcranial Doppler Ultrasound on Logistics and Outcomes in Stroke Thrombolysis: Results From the SITS-ISTR”" @default.
• W2897078483 cites W2807282135 @default.
• W2897078483 doi "https://doi.org/10.1161/strokeaha.118.022660" @default.
• W2897078483 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30355223" @default.
• W2897078483 hasPublicationYear "2018" @default.
• W2897078483 type Work @default.
• W2897078483 sameAs 2897078483 @default.
• W2897078483 citedByCount "1" @default.
• W2897078483 countsByYear W28970784832023 @default.
• W2897078483 crossrefType "journal-article" @default.
• W2897078483 hasAuthorship W2897078483A5002192023 @default.
• W2897078483 hasAuthorship W2897078483A5015220387 @default.
• W2897078483 hasAuthorship W2897078483A5024953656 @default.
• W2897078483 hasBestOaLocation W28970784831 @default.
• W2897078483 hasConcept C121332964 @default.
• W2897078483 hasConcept C126322002 @default.
• W2897078483 hasConcept C126838900 @default.
• W2897078483 hasConcept C127413603 @default.
• W2897078483 hasConcept C1276947 @default.
• W2897078483 hasConcept C142757262 @default.
• W2897078483 hasConcept C143753070 @default.
• W2897078483 hasConcept C164705383 @default.
• W2897078483 hasConcept C1862650 @default.
• W2897078483 hasConcept C191616109 @default.
• W2897078483 hasConcept C2779581417 @default.
• W2897078483 hasConcept C2780645631 @default.
• W2897078483 hasConcept C2988078883 @default.
• W2897078483 hasConcept C500558357 @default.
• W2897078483 hasConcept C71924100 @default.
• W2897078483 hasConcept C78519656 @default.
• W2897078483 hasConcept C99508421 @default.
• W2897078483 hasConceptScore W2897078483C121332964 @default.
• W2897078483 hasConceptScore W2897078483C126322002 @default.
• W2897078483 hasConceptScore W2897078483C126838900 @default.
• W2897078483 hasConceptScore W2897078483C127413603 @default.
• W2897078483 hasConceptScore W2897078483C1276947 @default.
• W2897078483 hasConceptScore W2897078483C142757262 @default.
• W2897078483 hasConceptScore W2897078483C143753070 @default.
• W2897078483 hasConceptScore W2897078483C164705383 @default.
• W2897078483 hasConceptScore W2897078483C1862650 @default.
• W2897078483 hasConceptScore W2897078483C191616109 @default.
• W2897078483 hasConceptScore W2897078483C2779581417 @default.
• W2897078483 hasConceptScore W2897078483C2780645631 @default.
• W2897078483 hasConceptScore W2897078483C2988078883 @default.
• W2897078483 hasConceptScore W2897078483C500558357 @default.
• W2897078483 hasConceptScore W2897078483C71924100 @default.
• W2897078483 hasConceptScore W2897078483C78519656 @default.
• W2897078483 hasConceptScore W2897078483C99508421 @default.
• W2897078483 hasIssue "11" @default.
• W2897078483 hasLocation W28970784831 @default.
• W2897078483 hasLocation W28970784832 @default.
• W2897078483 hasOpenAccess W2897078483 @default.
• W2897078483 hasPrimaryLocation W28970784831 @default.
• W2897078483 hasRelatedWork W1995121798 @default.
• W2897078483 hasRelatedWork W2116772419 @default.
• W2897078483 hasRelatedWork W2137903930 @default.
• W2897078483 hasRelatedWork W2248226458 @default.
• W2897078483 hasRelatedWork W2361940821 @default.
• W2897078483 hasRelatedWork W2377738080 @default.
• W2897078483 hasRelatedWork W2897078483 @default.
• W2897078483 hasRelatedWork W2897293507 @default.
• W2897078483 hasRelatedWork W3184843553 @default.
• W2897078483 hasRelatedWork W3029790957 @default.
• W2897078483 hasVolume "49" @default.
• W2897078483 isParatext "false" @default.
• W2897078483 isRetracted "false" @default.
• W2897078483 magId "2897078483" @default.
• W2897078483 workType "article" @default.